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ABSTRACT
Background: Individuals diagnosed with schizophrenia are often assigned other psychiatric diagnoses
during their lives. The significance of changing diagnosis has not been widely studied.
Aims: Our aim was to examine the association between diagnostic change and later outcome.
Methods: Individuals’ diagnostic history, clinical and social outcomes were extracted from the AESOP-
10 study, a 10-year follow-up of first episode psychosis cases. The association between outcome and
different patterns of diagnosis over time were assessed using linear or logistic regression.
Results: Individuals always diagnosed with schizophrenia (n¼ 136) had worse clinical and social out-
comes at follow-up than those never diagnosed with schizophrenia (n¼ 163), being more likely to be
symptomatic, unemployed, single, and socially isolated. There was no difference in outcome between
individuals always diagnosed with schizophrenia and those changing to a diagnosis of schizophrenia
(n¼ 60), and no difference in outcome between individuals never diagnosed with schizophrenia, and
those changing from a diagnosis of schizophrenia (n¼ 44).
Conclusions: Individuals always and never diagnosed with schizophrenia had different outcomes. In
cases of diagnostic instability participants had similar outcomes to those always assigned the diagnosis
they changed to irrespective of initial diagnosis.
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Introduction
The validity of psychiatric diagnoses has been a topic of interest
for researchers for several decades. Diagnostic categories in
psychiatry are in general based on subjective features of the
patient experience as opposed to underlying neuropathology
(Parnas, 2014). This has led to changes in their accepted defini-
tions over time, which in turn may change the characteristics
of patients in these groups (Tandon et al., 2013).
In addition to changes over time in the accepted charac-
teristics of diagnoses there has been interest in monitoring
individual patients’ own changes between diagnostic catego-
ries. As early as 1967 it was observed that patients did not
necessarily keep the same assigned diagnosis throughout
their disease course (Cooper, 1967). The vast majority of
subsequent research in this area has focused on schizophre-
nia; Schwartz et al (Schwartz et al., 2000) in 2000 reported a
92% stability of schizophrenia diagnosis over 6 months, a
figure broadly in keeping with subsequent studies; 91%
(30 months) reported by Veen et al. (2004), 100%
(6 months) reported by Baldwin et al (Baldwin et al., 2005),
97% (24 months) reported by Whitty et al. (2005), 91.3%
(variable) by Kim et al. (2011), and 72.9% (variable, max
96 months) by Heslin et al. (2015). A 2016 meta-analysis of
42 studies of diagnostic stability reported a 90% stability of
schizophrenia diagnoses (Fusar-Poli et al., 2016).
Many studies have also investigated predictors of diagnos-
tic instability, with the vast majority focused on schizophre-
nia. Variables positively predicting a future change to a
diagnosis of schizophrenia from another initial diagnosis
include; longer initial duration of untreated psychosis (Chang
et al., 2009; Haahr et al., 2008; Heslin et al., 2015; Schwartz
et al., 2000), no history of substance misuse (Salvatore et al.,
2011; Schwartz et al., 2000), longer initial duration of
inpatient treatment (Queirazza et al., 2014; Schwartz et al.,
2000), experiencing social isolation (Heslin et al., 2015) and
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initial greater severity of symptoms (Bromet et al., 2005;
Heslin et al., 2015; Pillmann et al., 2012; Schwartz et al., 2000;
Schimmelmann et al., 2005). Conversely, however, Fusar-
Poli et al. (2016) in a meta-analysis of 42 studies did not
find any single variable associated with future diagnostic
instability.
Despite many studies commenting on antecedents of
diagnostic instability there does not exist nearly the same
level of interest in the literature regarding sequelae of diag-
nostic instability. Bromet et al. (2005) reported on diagnos-
tic instability as a predictor of outcome, finding that
patients assigned a DSM-III diagnosis of schizophrenia at
any time had worse outcomes (measured using the Global
Assessment of Functioning Questionnaire) than those diag-
nosed with other psychotic illnesses. They also found that
patients who change to a diagnosis of schizophrenia from
other diagnoses have similar outcomes to those always
assigned a diagnosis of schizophrenia, although they did not
present a detailed statistical analysis of their data (Bromet
et al., 2005). Since then no other study has reported in
detail on the effect of diagnostic instability on outcomes in
psychosis, although Addington et al. (2006) did track a var-
iety of social and clinical demographics over a one- year
period in a first episode psychosis cohort and observed no
outcome difference between individuals diagnosed with
schizophrenia at baseline and individuals changing to a
diagnosis of schizophrenia (Addington et al., 2006).
In this study we present an analysis of diagnostic
instability as a predictor of outcome in a cohort of first epi-
sode psychosis patients over 10 years monitored as part of
the Aetiology and Ethnicity in Schizophrenia and Other
Psychoses (AESOP) study. We have sought to fulfil two
main aims; (1) to examine the effect of experiencing any
diagnostic instability on clinical and social outcomes in first
episode psychosis, and (2) to examine the significance of
diagnostic instability in those finally assigned a diagnosis of
schizophrenia—specifically, do individuals with a different
initial diagnosis have any difference in outcome to those
always diagnosed with schizophrenia?
Method
Sample
AESOP-10 is a follow-up at approximately 10 years of a
cohort of 557 individuals with a first episode of psychosis
initially identified in the South East London and
Nottingham centres of the Aetiology and Ethnicity in
Schizophrenia and Other Psychoses (AESOP) study
(Kirkbride et al., 2006). Potential cases aged between 16 and
65 were screened for inclusion using the Screening Schedule
for Psychosis (Jablensky et al., 1992). This questionnaire was
not however used to assign diagnoses.
Data collection and follow-up
Clinical and demographic data were collected at baseline
using the Medical Research Council Social Demographic
Schedule (Mallett, 1997). The Schedules for Clinical
Assessment in Neuropsychiatry (SCAN) were used in order
to elicit symptom related data at the time of presentation
(World Health Organization & Division of Mental Health,
1994). If the full version of the latter could not be adminis-
tered the Item Group Checklist component was completed
using clinical records.
Individuals were followed-up over a period of 10 years
after first contact. The World Health Organisation (WHO)
Life Chart (Susser et al., 2000) was completed for each indi-
vidual, and at the end of follow-up the SCAN was again
administered (considering the previous 30 days). The WHO
Life Chart was completed for each patient using clinical
interviews with patients and information from treating clini-
cians and clinical notes otherwise. This included symptom
profile, use of psychiatric services, use of illicit drugs and
alcohol, socio-economic indicators including housing, rela-
tionship and employment data, and forensic data regarding
the follow-up period.
Diagnoses
Diagnoses at both enrolment and followup were made by
committee consensus using the International Classification
of Diseases Version 10 (ICD-10) (World Health
Organization, 1992). At baseline this was based on all avail-
able clinical and demographic information available in the
clinical records including the baseline SCAN or if a patient
interview was available the Item Group Checklist (com-
pleted from case notes). At follow-up this included the fol-
low-up SCAN or Item Group Checklist plus the Life Chart
and all other available clinical information. The committee
assigning diagnoses consisted of at least one principle inves-
tigator of the study, one psychiatrist and one other member
of the research team. All diagnoses were made blind to eth-
nicity and to diagnoses assigned by the treating clin-
ical team.
Statistical analysis
Statistical analysis was performed using STATA 14
(StataCorp LLC, Texas, USA). Associations between diag-
nostic change and individual outcomes were assessed using
logistic or linear regression analyses, with number of com-
munity treatment episodes during follow-up, number of
hospital admissions during follow-up, longest remission dur-
ing follow-up and time spent in prison during follow-up
considered as continuous outcomes, and the remainder as
binary outcomes. All models included age, ethnicity, and
study centre (London or Nottingham) as covariates.
Ethics
Local research ethics committees in South East London and
Nottingham provided full ethical approval for all aspects of
the follow-up (reference number: 05/Q0706/158). All
researchers had substantive or honorary contracts with
either the South London and Maudsley National Health
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Service (NHS) Foundation Trust or the Nottingham
Healthcare NHS Trust, the primary participating service
providers. All participants gave consent for their data to be
used in research.
Results
Sample
Data presented here are based on the incidence sample of
505 patients collected over the first two years of the AESOP
study. Of these, 102 (20.2%) individuals were lost to follow-up
during the ensuing 10 years; thus 403 (79.8%) individuals are
included in this analysis. Table 1 shows the difference in base-
line demographic and clinical variables between those followed
up and not followed up. There were no differences between
groups by gender, age, diagnosis, or duration of untreated
psychosis. There was, however, a difference between those fol-
lowed-up and those not followed-up in terms of ethnicity
(Table 1).
Diagnoses and diagnostic change
At baseline 180 individuals (44.7%) had a diagnosis of
schizophrenia (F20), 56 (13.9%) bipolar disorder with
psychotic symptoms (F31), 55 (13.6%) depression with
psychotic symptoms (F32.3, F33.3), 25 (6.2%) schizoaffective
disorder (F25.9), 23 (5.7%) acute and transient psychotic
disorders (F23) and the remaining 64 (15.8%) psychosis
not otherwise specified. At follow-up, 196 (48.6%) had been
assigned schizophrenia diagnoses, 61 (15.1%) bipolar dis-
order diagnoses, and 37 (9.2%) schizoaffective dis-
order diagnoses.
240 individuals (59.6%) retained the same diagnosis
throughout the follow-up period, and 163 (40.5%) did not.
Regarding schizophrenia specifically 136 (33.8%) individ-
uals were stably assigned a schizophrenia diagnosis through-
out the study period (Always SZ), 60 (14.9%) changed to a
diagnosis at final followup of schizophrenia from another
initial assigned diagnoses (Followup SZ), 44 (10.9%)
changed from an initial diagnosis of schizophrenia to
another diagnosis at follow-up (Initial SZ), and 163 individ-
uals (40.5%) were never diagnosed with schizophrenia
(Never SZ). The summary statistics relating to each of these
four groups are listed in Appendices Tables A1–A4.
Diagnoses and outcomes
Individuals who experienced any change in diagnosis during
the study period (n¼ 163, 40.5%) did not in general demon-
strate different outcomes to those who had a stable diagno-
sis (n¼ 240, 59.6%), although they were less likely to be
experiencing psychotic symptoms at the end of follow-up
(OR 0.555, 95% CI 0.335 0.921). There was no obvious
difference observed in any social outcome between the
two groups.
When outcomes were compared between Never SZ indi-
viduals (n¼ 163) and Always SZ individuals (n¼ 136) those
assigned a schizophrenia diagnosis had worse outcomes
across a variety of clinical and social domains (Table 2).
Unsurprisingly the most pronounced differences were in
symptom profile; 53.0% of the Always SZ group had experi-
enced psychotic phenomena within 30 days of the end of
follow-up and 42.5% negative symptoms, compared to
14.9% (psychotic symptoms) and 11.3% (negative symp-
toms) of the Never SZ group (psychotic symptoms OR
6.066 95% CI 3.065 11.199; negative symptoms OR 5.618,
95% CI 2.824–11.364).
Table 1. Comparison of baseline demographic and diagnostic variables between those successfully followed up (included) and not followed up (excluded) over 10 years.
Followed up Not followed up Test statistic p
n 403 (79.8%) 102 (20.2%) chi2
Gender 0.735 (1) 0.391
Male 230 (57.1%) 63 (61.8%)
Female 173 (42.9%) 39 (38.2%)
Baseline diagnosis 1.712 (8) 0.989
Schizophrenia 177 (43.9%) 41 (40.0%)
Psychotic Major Depression 55 (13.6%) 17 (16.7%)
Bipolar Disorder 56 (13.9%) 15 (14.7%)
Schizoaffective Disorder 25 (6.2%) 5 (4.9%)
Delusional Disorder 19 (4.7%) 4 (3.9%)
Psychosis Not Otherwise Specified 27 (6.7%) 8 (7.8%)
Acute and Transient Psychotic Disorder 23 (5.7%) 7 (6.86%)
Drug Induced Psychosis 21 (20.4%) 5 (4.9%)
Ethnicity 11.38 (5) 0.04
White British 185 (45.9%) 43 (42.1%)
African-Carribbean 101 (25.0%) 18 (17.6%)
Black African 48 (11.9%) 17 (16.7%)
other white 26 (6.5%) 10 (9.8%)
other 43 (10.7%) 14 (13.7%)
Wilcoxon z
Age at initial contact (whole years) 1.617 0.106
Median 29 27
IQR 22–36 22–33
Duration of untreated psychosis (whole days) 0.248 0.804
Median 60 56
IQR 15–238 15–184
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Significant differences were also observed in social out-
comes; 82.9% of the Always SZ group were not in a roman-
tic relationship at the time of follow-up compared to 58.1%
of the Never SZ group (OR 3.094, 95% CI 1.712–5.590).
13.2% of the Always SZ group were employed (full or part
time) at the end of the follow-up period, compared to
36.7% of the Never SZ group (OR 4.790, 95% CI
2.244–10.229). Compared to the Always SZ group the Never
SZ group were also more likely to spend time with friends,
spent less time in prison, were less likely to live in social
housing, and less likely to misuse alcohol (although the lat-
ter two findings were not statistically significant).
Conversely there was no difference observed between groups
in terms of antisocial behaviour.
Comparing the Followup SZ group with the Always SZ
group demonstrated no clear difference in clinical or social
outcome (Table 3), although there was a weak association
between always being diagnosed with schizophrenia and
experiencing psychotic symptoms at follow-up endpoint
(OR 1.728, 95% CI 0.857–3.497).
There were also no clear differences observed when com-
paring the Initial SZ group (n¼ 44) with the Never SZ
group (n¼ 163) (Table 4).
Discussion
Individuals stably diagnosed with schizophrenia (Always SZ)
and never diagnosed with schizophrenia (Never SZ) have
markedly differing clinical and social outcomes (with the
schizophrenia cohort having less favourable outcomes).
There is however no discernible difference in outcome
between those always diagnosed with schizophrenia (Always
SZ) and those initially assigned another diagnostic category
before moving to a diagnosis of schizophrenia (Followup
SZ), nor those moving from a diagnosis of schizophrenia to
other diagnoses (Initial SZ) and those never diagnosed with
schizophrenia (Never SZ). This lack of difference is some-
what surprising.
Table 2. Comparison of clinical and social outcomes in those never diagnosed with schizophrenia (Never SZ) (n¼ 163) vs those stably diagnosed with schizo-
phrenia (Always SZ) (n¼ 136).
Exposure Outcome
Regression
coefficient Odds ratio 95% 95% p
Individuals permanently
diagnosed with
schizophrenia
(compared to those
never diagnosed with
schizophrenia)
Experiencing positive symptoms at end of follow-up 6.07 3.06 11.20 <0.001
Experiencing negative symptoms at end of follow-up 5.62 2.82 11.36 <0.001
Having experienced non-psychotic illness during follow-up 3.65 2.00 6.67 <0.001
Having experienced at least 1 suicide attempt during follow-up 1.87 0.92 3.76 0.08
Having experienced at least 1 episode of self-harm during follow-up 1.46 0.67 3.21 0.328
Number of community treatment episodes during follow-up 0.86 0.10 1.62 0.026
Number of hospital admissions during follow-up 0.30 0.06 0.66 0.101
Longest remission during follow-up (weeks) 197.63 251.54 143.72 <0.001
Experiencing social Isolation at the end of follow-up period 3.26 1.41 7.56 0.006
Time spent in prison during follow-up (months) 1.29 0.45 2.14 0.003
Displaying any antisocial behaviour during follow-up 1.02 0.57 1.83 0.947
Harmful alcohol use during follow-up 1.61 0.88 2.96 0.122
Living with family or friends at end of follow-up period 0.67 0.40 1.11 0.122
Living in social housing at end of follow-up 1.88 0.92 3.87 0.080
Being unemployed at the end of follow-up 4.79 2.24 10.23 <0.001
Having no close friends at the end of follow-up 3.27 1.41 7.58 0.006
Not being in a romantic relationship at the end of follow-up 3.09 1.71 5.59 <0.001
Table 3. Comparison of clinical and social outcomes in those stably diagnosed with schizophrenia (Always SZ) (n¼ 136) vs those initially assigned another diag-
nosis before changing to a diagnosis of schizophrenia (Followup SZ) (n¼ 60).
Exposure Outcome
Regression
Coefficient Odds Ratio 95% 95% p
Individuals permanently
diagnosed with
schizophrenia
(compared to those
changing to a
schizophrenia
diagnosis from another
initial diagnosis)
Experiencing positive symptoms at end of follow-up 1.73 0.86 3.50 0.126
Experiencing negative symptoms at end of follow-up 0.87 0.43 1.746 0.693
Having experienced non-psychotic illness during follow-up 1.23 0.54 2.80 0.622
Having experienced at least 1 suicide attempt during follow-up 1.46 0.61 3.48 0.391
Having experienced at least 1 episode of self-harm during follow-up 1.45 0.56 3.7 0.447
Number of community treatment episodes during follow-up 0.11 0.87 1.09 0.825
Number of hospital admissions during follow-up 0.01 0.48 0.49 0.978
Longest remission during follow-up (weeks) 35.60 23.74 94.95 0.238
Experiencing social Isolation at the end of follow-up period 0.89 0.33 2.37 0.809
Time spent in prison during follow-up (months) 0.14 1.96 2.23 0.899
Displaying any antisocial behaviour during follow-up 0.82 0.39 1.70 0.586
Harmful alcohol use during follow-up 0.91 0.42 1.94 0.798
Living with family or friends at end of follow-up period 0.75 0.38 1.46 0.400
Living in social housing at end of follow-up 0.99 0.40 2.40 0.976
Being unemployed at the end of follow-up 0.65 0.21 2.06 0.467
Having no close friends at the end of follow-up 1.13 0.42 3.02 0.809
Not being in a romantic relationship at the end of follow-up 0.75 0.31 1.84 0.531
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There are very few studies to compare these findings to,
although the limited number that exist in general similarly
demonstrate no differences in outcome between Always SZ
and Followup SZ groups. Addington and colleagues
(Addington et al., 2006) hypothesised that individuals who
were observed during their one-year study period to change
to a diagnosis of schizophrenia from other diagnoses were
simply “earlier in the course of their illness” and thus did
not meet the diagnostic threshold at the time of inclusion
into the cohort. Fraguas et al in 2007 support this hypoth-
esis also, finding that baseline diagnosis was consistent from
first presentation to one-year follow-up in 54.2% of first epi-
sode psychosis patients, but that between one and two years
diagnosis was consistent in 95.7% of patients. The authors
suggested that some individuals managed to access health-
care very early in their disease course, and that the full
extent of their symptoms may not yet have manifested at
initial interview (Fraguas et al., 2008).
Alavi et al. (2014) reported a similar pattern of findings
in a cohort of first episode psychosis individuals in Iran,
and theorised that many who change to diagnoses of schizo-
phrenia after a different initial diagnoses do so due to clin-
ician behaviour; a diagnosis of schizophrenia carries a
significant stigma burden, even amongst healthcare profes-
sionals (Henderson et al., 2014), and the authors proposed
that clinicians are likely to wish to assign non-schizophrenia
diagnoses until they are certain of the illness course, giving
rise to apparent diagnostic instability.
Whilst clinician behaviour and fear of stigma may play a
role in some studies this is not likely a factor in this cohort
(or in the vast majority of other studies of diagnostic
instability available in the literature) as diagnostic data used
here is made by consensus of the research team and does
not directly influence patient care. It is notable that some
published studies reporting particularly high rates of diag-
nostic instability in first episode psychosis use clinical rather
than research diagnoses (Alavi et al., 2014; Baca-Garcia
et al., 2007).
Although it may be the case that the Followup SZ group
in our study were simply earlier in their illness course at
initial presentation this theory does not fully explain the
lack of difference in outcomes observed between those with
stable and unstable schizophrenia diagnoses. It is widely
proposed that prompt intervention and treatment in first
episode psychosis improves clinical and social outcomes
(McGorry, 2015). If therefore the Followup SZ group are
simply accessing healthcare earlier in their disease course it
may be reasonably expected that they would have improved
outcomes when compared to the Always SZ group (who
theoretically presented later in their illness course)—how-
ever neither this study nor any other has ever shown this to
be the case. The existence of the Initial SZ group (n¼ 44) in
this study, who experienced better clinical and social out-
comes, could be viewed as reason for clinicians to not be
fatalistic when observing poor prognostic indicators early in
illness course.
There were some unexpected findings in this analysis—
notably when comparing Always SZ and Never SZ groups
there was no difference observed in presence of antisocial
behaviour, alcohol use, or substance dependence. In other
studies poor outcomes in all of these individual domains
have been demonstrated in individuals assigned schizophre-
nia diagnoses (Capdevielle et al., 2009; Fazel et al., 2009;
Richter & Hoffmann, 2019; Saha et al., 2007; Samele et al.,
2013), and it is not clear why these findings have not been
replicated here.
One possible explanation is the use of research diagnoses
as discussed above; JE Cooper in 1967, the first researcher
to comment on diagnostic instability, concluded that
changes in diagnosis were solely due to changes in treating
doctor (Cooper, 1967), and it is possible that clinician
behaviour has a significant impact on patient outcome, and
that this is not being represented in studies using research
diagnoses. An initial avenue for further investigation would
be to repeat this study using clinical diagnoses.
The use of research diagnoses is therefore a potential
weakness in this study; research diagnostic rates may not
reflect those observed in clinical practice (Moilanen et al,
2003). The use of ICD diagnoses in this study may further
limit the generalisability of these results to settings which
Table 4. Comparison of clinical and social outcomes in those vs those changing from an initial schizophrenia diagnosis to a diagnosis other than schizophrenia
(Initial SZ) (n¼ 44) vs those never diagnosed with schizophrenia (Never SZ) (n¼ 163).
Exposure Outcome
Regression
Coefficient Odds Ratio 95% 95% p
Individuals initially
diagnosed with
schizophrenia before
changing to another
diagnosis (compared
to those never
diagnosed with
schizophrenia)
Experiencing positive symptoms at end of follow-up 0.56 0.19 1.53 0.245
Experiencing negative symptoms at end of follow-up 1.00 0.26 3.44 0.991
Having experienced non-psychotic illness during follow-up 1.28 0.60 2.71 0.521
Having experienced at least 1 suicide attempt during follow-up 0.86 0.36 2.07 0.733
Having experienced at least 1 episode of self-harm during follow-up 0.96 0.35 2.65 0.938
Number of community treatment episodes during follow-up 0.03 1.02 0.97 0.961
Number of hospital admissions during follow-up 0.07 0.38 0.51 0.769
Longest remission during follow-up (weeks) 27.68 54.36 109.73 0.506
Experiencing social Isolation at the end of follow-up period 2.03 0.46 9.92 0.348
Time spent in prison during follow-up (months) 0.34 2.39 2.32 0.977
Displaying any antisocial behaviour during follow-up 0.81 0.32 2.05 0.660
Harmful alcohol use during follow-up 0.86 0.37 2.02 0.735
Living with family or friends at end of follow-up period 0.75 0.36 1.58 0.450
Living in social housing at end of follow-up 1.22 0.45 3.30 0.691
Being unemployed at the end of follow-up 2.10 0.77 5.70 0.145
Having no close friends at the end of follow-up 0.49 0.11 2.16 0.348
Not being in a romantic relationship at the end of follow-up 1.58 0.71 3.51 0.266
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use DSM, in which the schizophrenia diagnostic criteria are
less broad (Cheniaux et al., 2009). It important to note how-
ever that in their 2016 meta-analysis Fusar Poli et al. did
not observe any difference in diagnostic stability between
ICD and DSM schizophrenia diagnoses (Fusar-Poli et al.,
2016). There is an additional notable inherent limitation; as
with any cohort study loss to follow-up gives rise to poten-
tial bias. In this instance there was a statistically significant
difference in the ethnicity of those followed up and lost to
follow-up (Table 1), although there were no other differen-
ces between the cohorts, and only 20.2% of individuals did
not complete the study. Another inherent limitation is in
the complexity of the outcomes chosen—there are many fac-
tors beyond psychiatric diagnosis which might influence an
individual’s marital, housing or employment status, for
example, and it is impossible to account for all these with
the dataset available.
In summary diagnostic instability is not associated with
widespread difference in patient outcomes in this 10 year
cohort study of first episode psychosis patients, and nor is
there any demonstrated difference in outcome between
those changing to a schizophrenia diagnosis from another
initial diagnosis (Followup SZ) and those always diagnosed
with schizophrenia (Always SZ). There is also no significant
difference in outcome observed between those moving from
a diagnosis of schizophrenia to other diagnoses (Initial SZ),
and those never diagnosed with schizophrenia (Never SZ).
It appears that only the final assigned diagnosis (be it
schizophrenia or another diagnosis) correlates with clinical
and social outcomes in this cohort of first episode psychosis
patients. This is an interesting finding which raises ques-
tions as to the utility of initial diagnoses, and further work
in this area is merited.
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Appendix
Table A1. Summary data used in analyses; individuals always diagnosed with Schizophrenia (Always SZ) (n¼ 136).
Outcome Y (%) N (%) Mean
Experiencing positive symptoms at end of follow-up 53.0 47.0
Experiencing negative symptoms at end of follow-up 42.5 57.5
Having experienced non-psychotic illness during follow-up 22.2 77.8
Having experienced at least 1 suicide attempt during follow-up 14.9 85.1
Having experienced at least 1 episode of self-harm during follow-up 12.5 87.5
Number of community treatment episodes during follow-up 4.0
Number of hospital admissions during follow-up 3.9
Longest remission during follow-up (weeks) 133.5
Experiencing social Isolation at the end of follow-up period 29.1 70.9
Time spent in prison during follow-up (months) 1.4
Displaying any antisocial behaviour during follow-up 51.6 48.3
Harmful alcohol use during follow-up 44.3 55.7
Living with family or friends at end of follow-up period 49.2 50.8
Living in social housing at end of follow-up 62.7 37.3
Being unemployed at the end of follow-up 86.8 13.2
Having no close friends at the end of follow-up 29.1 70.9
Not being in a romantic relationship at the end of follow-up 17.1 82.9
Table A2. Summary data used in analyses; individuals changing to a diagnosis of Schizophrenia (Followup SZ) (n¼ 60).
Outcome Y (%) N (%) Mean
Experiencing positive symptoms at end of follow-up 38.9 57.4
Experiencing negative symptoms at end of follow-up 36.4 63.6
Having experienced non-psychotic illness during follow-up 25.9 74.1
Having experienced at least 1 suicide attempt during follow-up 20.3 83.3
Having experienced at least 1 episode of self-harm during follow-up 16.7 83.3
Number of community treatment episodes during follow-up 4.1
Number of hospital admissions during follow-up 3.7
Longest remission during follow-up (weeks) 160.1
Experiencing social Isolation at the end of follow-up period 31.0 68.9
Time spent in prison during follow-up (months) 1.0
Displaying any antisocial behaviour during follow-up 47.1 52.8
Harmful alcohol use during follow-up 40.0 60.0
Living with family or friends at end of follow-up period 43.9 56.1
Living in social housing at end of follow-up 64.9 35.1
Being unemployed at the end of follow-up 89.6 10.4
Having no close friends at the end of follow-up 31.0 69.0
Not being in a romantic relationship at the end of follow-up 16.3 83.6
Table A3. Summary data used in analyses; changing from a diagnosis of Schizophrenia (Initial SZ) (n¼ 44).
Outcome Y (%) N (%) Mean
Experiencing positive symptoms at end of follow-up 25.7 74.2
Experiencing negative symptoms at end of follow-up 9.7 90.2
Having experienced non-psychotic illness during follow-up 43.9 56.0
Having experienced at least 1 suicide attempt during follow-up 28.9 71.0
Having experienced at least 1 episode of self-harm during follow-up 18.4 81.6
Number of community treatment episodes during follow-up 2.9
Number of hospital admissions during follow-up 2.4
Longest remission during follow-up (weeks) 294.2
Experiencing social Isolation at the end of follow-up period 20.0 80.0
Time spent in prison during follow-up (months) 2.1
Displaying any antisocial behaviour during follow-up 50.0 50.0
Harmful alcohol use during follow-up 50.0 50.0
Living with family or friends at end of follow-up period 63.6 36.3
Living in social housing at end of follow-up 56.0 44.0
Being unemployed at the end of follow-up 75.8 24.2
Having no close friends at the end of follow-up 20.0 80.0
Not being in a romantic relationship at the end of follow-up 29.3 70.7
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Table A4. Summary data used in analyses; individuals never diagnosed with Schizophrenia (Never SZ) (n¼ 163).
Outcome Y (%) N (%) Mean
Experiencing positive symptoms at end of follow-up 14.9 85.1
Experiencing negative symptoms at end of follow-up 11.2 88.7
Having experienced non-psychotic illness during follow-up 54.9 45.1
Having experienced at least 1 suicide attempt during follow-up 25.0 75.0
Having experienced at least 1 episode of self-harm during follow-up 19.4 80.6
Number of community treatment episodes during follow-up 3.0
Number of hospital admissions during follow-up 2.6
Longest remission during follow-up (weeks) 329.6
Experiencing social Isolation at the end of follow-up period 11.2 88.8
Time spent in prison during follow-up (months) 1.1
Displaying any antisocial behaviour during follow-up 40.9 59.0
Harmful alcohol use during follow-up 43.6 56.4
Living with family or friends at end of follow-up period 58.9 41.1
Living in social housing at end of follow-up 45.6 54.3
Being unemployed at the end of follow-up 63.3 36.7
Having no close friends at the end of follow-up 11.2 88.8
Not being in a romantic relationship at the end of follow-up 41.9 58.1
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